# GlucoCEST MRI in Oncology

> **NCT03212157** · NA · COMPLETED · sponsor: **University College, London** · enrollment: 15 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma
- Lymphoma
- Glioma

## Interventions

- **OTHER:** Glucose infusion
- **DIAGNOSTIC_TEST:** Magnetic Resonance Imaging (MRI)
- **DIAGNOSTIC_TEST:** FDG PET

## Key facts

- **NCT ID:** NCT03212157
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-06
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-10-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03212157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03212157, "GlucoCEST MRI in Oncology". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03212157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*